Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Impact of HLA-B leader on clinical outcomes.

Data availability

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.


  1. Xu LP, Lu PH, Wu DP, Sun ZM, Liu QF, Han MZ, et al. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transpl. 2021;56:2940–7.

    Article  Google Scholar 

  2. Klein J, Sato A. The HLA system. First of two parts. N. Engl J Med. 2000;343:702–9.

    Article  Google Scholar 

  3. Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, et al. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med. 2008;205:725–35.

    Article  Google Scholar 

  4. Das J, Khakoo SI. NK cells: tuned by peptide? Immunol Rev. 2015;267:214–27.

    Article  Google Scholar 

  5. Merino AM, Sabbaj S, Easlick J, Goepfert P, Kaslow RA, Tang J. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clin Exp Immunol. 2013;174:414–23.

    Article  Google Scholar 

  6. Sajulga R, Bolon YT, Maiers MJ, Petersdorf EW. Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation. Blood Adv. 2022;6:270–80.

    Google Scholar 

  7. Petersdorf EW, Carrington M, O’HUigin C, Bengtsson M, De Santis D, Dubois V, et al. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study. Lancet Haematol. 2020;7:e50–e60.

    Article  Google Scholar 

  8. Petersdorf EW, Stevenson P, Bengtsson M, De Santis D, Dubois V, Gooley T, et al. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation. Blood. 2020;136:362–9.

    Google Scholar 

  9. Petersdorf EW, Gooley T, Volt F, Kenzey C, Madrigal A, McKallor C, et al. Use of the HLA-B leader to optimize cord blood transplantation. Haematologica. 2021;106:3107–14.

    Article  Google Scholar 

  10. Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MR, Modi D, et al. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide. Blood. 2022;139:1452–68.

    Article  Google Scholar 

  11. Dahlberg A, Milano F. Cord blood transplantation: rewind to fast forward. Bone Marrow Transpl. 2017;52:799–802.

    Article  Google Scholar 

  12. Ando T, Tachibana T, Tanaka M, Suzuki T, Ishiyama Y, Koyama S, et al. Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation. Blood Adv. 2020;4:408–19.

    Article  Google Scholar 

Download references


This work was supported by grants from the National Nature Science Foundation of China (No. 82170217 to AP, No. 82070192 and No. 81670171 to EJ), Haihe Laboratory of Cell Ecosystem Innovation Fund (No. HH22KYZX0034 to EJ), Fundamental Research Funds for the central universities (No. 3332020052 to YC), CAMS Innovation Fund for Medical Sciences (No. 2021-I2M-1-073 to AP), and Key Project of Tianjin Natural Science Foundation (No. 20JCZDJC00410 to AP).

Author information

Authors and Affiliations



MW performed the research and analyzed the data. MW, WG, XZ, JW, JL, and YC collected patient demographics and transplantation data. RZ, XC, YH, WZ, QM, JW, and YH obtained follow-up clinical information. DY and AP supervised the study. MW, SF, EJ, and MH designed the research and wrote the paper. All authors edited and approved the final version of the manuscript.

Corresponding author

Correspondence to Erlie Jiang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, M., Guo, W., Zheng, X. et al. Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning. Bone Marrow Transplant 58, 94–96 (2023).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links